Raging Capital is Bullish on 1-800-FLOWERS.COM Inc. (FLWS)

Raging Capital Management, managed by William C. Martin, has disclosed upping its stake in 1-800-FLOWERS.COM Inc. (NASDAQ:FLWS). According to a new filing with the U.S. Securities and Exchange Commission, the fund now holds around 2.81 million class A common stock shares, up from 1.90 million shares held previously. The position is equivalent to 10.3% of class, and is passive by nature.


1-800-FLOWERS.COM Inc. (NASDAQ:FLWS) is a florist and gift shop engaged in business of delivering fresh flowers, gift baskets, gourmet foods, confections, candles, balloons and plush stuffed animals. The company has a market cap of $358.9 million.

For the fiscal 2014 third quarter, the company reported revenues from continuing operations of $179.6 million, compared with revenues from continuing operations of $191.6 million in the prior year period. The 6.3% decline was primarily driven by the shift of the Easter holiday into its fiscal fourth quarter, compared with the prior year when the holiday fell in the company’s fiscal third quarter, the company stated, adding that revenues were also impacted by severe winter weather beginning in January, as well as the winter storm that effected much of the country at the key Valentine holiday.

For the year, 1-800-FLOWERS.COM Inc. (NASDAQ:FLWS) anticipates to achieve revenue growth across all three of its business segments with consolidated revenue growth for the year in the low-to-mid-single-digit range. The company expects EBITDA and EPS for the year will be flat to down slightly compared with the prior year.

On Monday, 1-800-FLOWERS.COM Inc. (NASDAQ:FLWS) stock traded down by 0.71% to $5.60. The stock has P/E ratio of 30.40. Analysts have the consensus average target price of $7.13 for the stock, while the consensus average recommendation is ‘buy.’

Other largest shareholders of the company include Mario Gabelli’s Gamco Investors, which own 720,000 shares, and Ken Griffin’s Citadel Investment Group, which holds 306,206 shares.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!